The identified protein network revealed that STON2 modulate stemness in ovarian cancer cells via epigenetic effectors such as DNMT1, and therefore, STON2 has a role in ovarian cancer biology and could represent a therapeutic target [40]. This evidence concerns the gene DNMT1 and ovarian cancer.